Platinum-based Drug [EPC]

Platinum-based Drug [EPC] was reported 273901 times

Drugs of the Platinum-based Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DYSAESTHESIA PHARYNX 121 0.6914
1 RENAL SALT-WASTING SYNDROME 255 0.6505
2 RADIATION OESOPHAGITIS 183 0.4803
3 TUMOUR PERFORATION 137 0.4308
4 NON-CIRRHOTIC PORTAL HYPERTENSION 161 0.4282
5 DUCTAL ADENOCARCINOMA OF PANCREAS 115 0.4152
6 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 370 0.3907
7 OESOPHAGEAL FISTULA 119 0.3742
8 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 267 0.3350
9 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 736 0.3335
10 ANASTOMOTIC LEAK 227 0.3271
11 IMMUNE-MEDIATED HYPOTHYROIDISM 357 0.3165
12 IMMUNE-MEDIATED DERMATITIS 314 0.3115
13 IMMUNE-MEDIATED NEPHRITIS 146 0.3113
14 PORTAL VENOUS GAS 111 0.3058
15 GASTROINTESTINAL ANASTOMOTIC LEAK 118 0.3026
16 IMMUNE-MEDIATED RENAL DISORDER 122 0.2947
17 OTOTOXICITY 529 0.2858
18 IMMUNE-MEDIATED LUNG DISEASE 506 0.2773
19 MALIGNANT TRANSFORMATION 123 0.2739
20 IMMUNE-MEDIATED HEPATIC DISORDER 508 0.2602
21 IMMUNE-MEDIATED HYPOPHYSITIS 116 0.2572
22 HAEMATOTOXICITY 2332 0.2452
23 NEUTROPENIC SEPSIS 1741 0.2435
24 MYELOSUPPRESSION 8567 0.2376
25 COLORECTAL CANCER METASTATIC 553 0.2331
26 AORTIC THROMBOSIS 269 0.2327
27 GASTROINTESTINAL TOXICITY 1102 0.2292
28 IMMUNE-MEDIATED THYROIDITIS 113 0.2287
29 SKIN TOXICITY 1291 0.2282
30 IMMUNE-MEDIATED HEPATITIS 465 0.2275
31 MENINGITIS TUBERCULOUS 127 0.2272
32 RECALL PHENOMENON 189 0.2261
33 RADIATION PNEUMONITIS 477 0.2227
34 NEUTROPENIC COLITIS 460 0.2222
35 IMMUNE-MEDIATED ENCEPHALITIS 115 0.2174
36 RADIATION SKIN INJURY 252 0.2172
37 IMMUNE-MEDIATED ENTEROCOLITIS 780 0.2119
38 PERIPHERAL SENSORY NEUROPATHY 1201 0.2053
39 METASTASES TO PERITONEUM 516 0.2041
40 AORTITIS 140 0.2041
41 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 179 0.2039
42 TUMOUR NECROSIS 210 0.1987
43 NODULAR REGENERATIVE HYPERPLASIA 126 0.1963
44 THERAPY PARTIAL RESPONDER 2974 0.1905
45 FEBRILE NEUTROPENIA 12622 0.1901
46 IMMUNE-MEDIATED MYOCARDITIS 307 0.1900
47 NEUTROPENIC INFECTION 181 0.1891
48 MUCOSAL INFLAMMATION 4939 0.1885
49 INFUSION RELATED HYPERSENSITIVITY REACTION 112 0.1864
50 FEBRILE BONE MARROW APLASIA 784 0.1843
51 VENOOCCLUSIVE LIVER DISEASE 910 0.1841
52 BONE MARROW TOXICITY 216 0.1823
53 ARTERIOSPASM CORONARY 724 0.1803
54 GRANULOCYTE COUNT DECREASED 327 0.1762
55 LARYNGOSPASM 461 0.1712
56 NON-SMALL CELL LUNG CANCER 816 0.1702
57 NON-SMALL CELL LUNG CANCER METASTATIC 149 0.1695
58 LYMPHANGIOSIS CARCINOMATOSA 176 0.1689
59 DERMATITIS ACNEIFORM 964 0.1583
60 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 195 0.1565
61 METASTASES TO ADRENALS 141 0.1528
62 TUMOUR PSEUDOPROGRESSION 165 0.1507
63 GASTROINTESTINAL PERFORATION 623 0.1497
64 METASTASES TO MENINGES 337 0.1481
65 HYPERAMMONAEMIC ENCEPHALOPATHY 253 0.1454
66 HYPOMAGNESAEMIA 2017 0.1447
67 DEVICE RELATED THROMBOSIS 138 0.1400
68 PERIPHERAL MOTOR NEUROPATHY 195 0.1391
69 FOLLICULAR LYMPHOMA 122 0.1386
70 METASTASES TO SKIN 143 0.1384
71 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 108 0.1381
72 FULMINANT TYPE 1 DIABETES MELLITUS 142 0.1377
73 APLASIA 266 0.1357
74 PARONYCHIA 596 0.1355
75 ACUTE PROMYELOCYTIC LEUKAEMIA 138 0.1342
76 POLYNEUROPATHY 1598 0.1333
77 OVARIAN CANCER METASTATIC 113 0.1329
78 ENTEROCOLITIS 767 0.1327
79 NEUROTOXICITY 2327 0.1327
80 OVARIAN CANCER RECURRENT 213 0.1325
81 TUMOUR LYSIS SYNDROME 1165 0.1323
82 METASTASES TO PLEURA 138 0.1316
83 NEOPLASM RECURRENCE 446 0.1314
84 OESOPHAGEAL PERFORATION 109 0.1307
85 NEUTROPHIL COUNT DECREASED 5316 0.1303
86 BONE MARROW FAILURE 2644 0.1300
87 TYPE I HYPERSENSITIVITY 449 0.1274
88 PALMAR ERYTHEMA 146 0.1266
89 CARCINOEMBRYONIC ANTIGEN INCREASED 240 0.1238
90 PNEUMATOSIS INTESTINALIS 351 0.1229
91 HYPOPITUITARISM 214 0.1229
92 MYOCARDIAL INJURY 138 0.1227
93 LICHENOID KERATOSIS 279 0.1220
94 ACQUIRED GENE MUTATION 160 0.1220
95 NEUTROPHIL COUNT ABNORMAL 338 0.1195
96 ENTERITIS 762 0.1190
97 NEUTROPENIA 16156 0.1187
98 CARDIOTOXICITY 1053 0.1179
99 METASTASES TO LIVER 2063 0.1173
100 BICYTOPENIA 230 0.1172
101 PORTAL HYPERTENSION 361 0.1169
102 METASTASES TO LUNG 1352 0.1169
103 CULTURE URINE POSITIVE 164 0.1166
104 MALIGNANT PLEURAL EFFUSION 196 0.1161
105 CYTOPENIA 1422 0.1160
106 HYPOPHYSITIS 233 0.1157
107 CHOLANGITIS 713 0.1149
108 ENTEROCOLITIS INFECTIOUS 106 0.1148
109 DISEASE PROGRESSION 13602 0.1148
110 THROMBOCYTOPENIA 12825 0.1146
111 ADMINISTRATION SITE EXTRAVASATION 113 0.1131
112 METASTASES TO LYMPH NODES 763 0.1129
113 SYSTEMIC INFECTION 187 0.1127
114 VENA CAVA THROMBOSIS 187 0.1124
115 PANCYTOPENIA 6193 0.1107
116 SMALL INTESTINAL PERFORATION 207 0.1103
117 HYPOALBUMINAEMIA 855 0.1099
118 SMALL CELL LUNG CANCER 164 0.1085
119 OESOPHAGITIS 1186 0.1084
120 EMBOLISM ARTERIAL 128 0.1065
121 LYMPHADENOPATHY MEDIASTINAL 204 0.1064
122 SECOND PRIMARY MALIGNANCY 884 0.1062
123 ACUTE MYELOID LEUKAEMIA 1644 0.1054
124 MALIGNANT NEOPLASM PROGRESSION 10770 0.1051
125 PELVIC ABSCESS 120 0.1044
126 FEMALE GENITAL TRACT FISTULA 177 0.1036
127 PULMONARY TOXICITY 730 0.1031
128 LUNG ADENOCARCINOMA 310 0.1029
129 SUBCLAVIAN VEIN THROMBOSIS 117 0.1027
130 DIFFUSE LARGE B-CELL LYMPHOMA 789 0.1023
131 IMMUNE-MEDIATED ADVERSE REACTION 157 0.1022
132 SECONDARY ADRENOCORTICAL INSUFFICIENCY 154 0.1019
133 LEUKOPENIA 5051 0.1009
134 STRIDOR 297 0.1008
135 RENAL TUBULAR DISORDER 282 0.1001
136 MYELODYSPLASTIC SYNDROME 1447 0.0999
137 ORAL INTAKE REDUCED 241 0.0996
138 SUBILEUS 205 0.0984
139 TUMOUR HAEMORRHAGE 281 0.0984
140 METASTASES TO CENTRAL NERVOUS SYSTEM 1268 0.0982
141 ADENOCARCINOMA OF COLON 182 0.0971
142 ADENOCARCINOMA 217 0.0967
143 NEPHROPATHY TOXIC 1078 0.0959
144 ARTERIAL THROMBOSIS 184 0.0951
145 COLON CANCER METASTATIC 152 0.0942
146 LARGE INTESTINE PERFORATION 652 0.0938
147 PERIPHERAL SENSORIMOTOR NEUROPATHY 116 0.0923
148 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2146 0.0920
149 HEPATIC CYTOLYSIS 1170 0.0917
150 GASTRIC PERFORATION 248 0.0909
151 NEOPLASM PROGRESSION 3163 0.0909
152 BLOOD CULTURE POSITIVE 269 0.0898
153 PNEUMONITIS 2408 0.0883
154 FANCONI SYNDROME 124 0.0876
155 PERFORMANCE STATUS DECREASED 405 0.0867
156 INFECTIOUS PLEURAL EFFUSION 132 0.0867
157 RADIOTHERAPY 165 0.0862
158 IMMUNE THROMBOCYTOPENIA 395 0.0862
159 CYTOKINE RELEASE SYNDROME 1730 0.0862
160 NEUROPATHY PERIPHERAL 8194 0.0861
161 PERIPHERAL ISCHAEMIA 350 0.0856
162 JUGULAR VEIN THROMBOSIS 151 0.0848
163 LEUKOENCEPHALOPATHY 316 0.0848
164 TRANSITIONAL CELL CARCINOMA 109 0.0840
165 GENE MUTATION 165 0.0833
166 HYDRONEPHROSIS 624 0.0833
167 ENCEPHALITIS AUTOIMMUNE 107 0.0814
168 METASTASIS 579 0.0810
169 EMBOLISM 671 0.0807
170 HYPERTRANSAMINASAEMIA 561 0.0806
171 HYPOKALAEMIA 3703 0.0801
172 HYPOPROTEINAEMIA 152 0.0800
173 EXTREMITY NECROSIS 139 0.0796
174 LIVER ABSCESS 257 0.0791
175 BLOOD CHLORIDE DECREASED 203 0.0787
176 THYROIDITIS 235 0.0782
177 NEPHRITIS 259 0.0775
178 EMBOLISM VENOUS 235 0.0774
179 METASTATIC NEOPLASM 334 0.0774
180 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 732 0.0766
181 DYSAESTHESIA 235 0.0766
182 ADRENAL INSUFFICIENCY 911 0.0750
183 ASPERGILLUS INFECTION 490 0.0746
184 ESCHERICHIA BACTERAEMIA 174 0.0739
185 INTESTINAL ISCHAEMIA 403 0.0731
186 CAPILLARY LEAK SYNDROME 151 0.0730
187 ELECTROLYTE IMBALANCE 844 0.0726
188 VENOOCCLUSIVE DISEASE 181 0.0722
189 OESOPHAGEAL STENOSIS 205 0.0720
190 SEPTIC SHOCK 3126 0.0718
191 INTERSTITIAL LUNG DISEASE 3459 0.0714
192 THROMBOTIC MICROANGIOPATHY 696 0.0713
193 CYSTITIS HAEMORRHAGIC 287 0.0711
194 AUTOIMMUNE HAEMOLYTIC ANAEMIA 244 0.0711
195 EMPYEMA 141 0.0709
196 ILEUS 881 0.0708
197 GASTROINTESTINAL NECROSIS 206 0.0706
198 ANAEMIA 13320 0.0698
199 ASPARTATE AMINOTRANSFERASE ABNORMAL 106 0.0696
200 STRESS CARDIOMYOPATHY 403 0.0692
201 ONYCHOLYSIS 108 0.0691
202 HAEMOLYTIC URAEMIC SYNDROME 160 0.0690
203 INTESTINAL PERFORATION 765 0.0681
204 VENOUS THROMBOSIS 267 0.0680
205 ODYNOPHAGIA 399 0.0668
206 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 117 0.0657
207 MYOCARDITIS 751 0.0655
208 METASTASES TO BONE 1064 0.0648
209 LUNG CONSOLIDATION 181 0.0646
210 HYPERAMMONAEMIA 321 0.0641
211 VARICES OESOPHAGEAL 194 0.0641
212 CACHEXIA 330 0.0641
213 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 657 0.0639
214 FAILURE TO THRIVE 332 0.0639
215 HYPOCALCAEMIA 1208 0.0638
216 BLOOD LACTATE DEHYDROGENASE INCREASED 1010 0.0637
217 ASCITES 1863 0.0633
218 CHOLANGITIS SCLEROSING 130 0.0632
219 PROTEINURIA 1203 0.0632
220 HAIR DISORDER 521 0.0632
221 DISSEMINATED INTRAVASCULAR COAGULATION 890 0.0632
222 LUNG ABSCESS 132 0.0629
223 HYPOPHOSPHATAEMIA 464 0.0627
224 ADRENOCORTICAL INSUFFICIENCY ACUTE 122 0.0625
225 LOBAR PNEUMONIA 115 0.0621
226 VENOUS THROMBOSIS LIMB 128 0.0620
227 LEFT VENTRICULAR DYSFUNCTION 413 0.0616
228 COLITIS 2331 0.0614
229 PROCTITIS 172 0.0613
230 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 459 0.0611
231 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 201 0.0606
232 CANCER PAIN 155 0.0606
233 HYPERBILIRUBINAEMIA 628 0.0606
234 AZOTAEMIA 242 0.0605
235 HYPOVOLAEMIA 350 0.0598
236 PSYCHOLOGICAL TRAUMA 512 0.0593
237 DEAFNESS NEUROSENSORY 195 0.0592
238 HYPOVOLAEMIC SHOCK 283 0.0590
239 BLOOD ALBUMIN DECREASED 468 0.0589
240 BACTERAEMIA 700 0.0589
241 ORGANISING PNEUMONIA 292 0.0589
242 EXTRAVASATION 238 0.0579
243 PORTAL VEIN THROMBOSIS 187 0.0578
244 HYPERPYREXIA 245 0.0578
245 HEPATIC LESION 248 0.0573
246 METASTASES TO SPINE 192 0.0571
247 HICCUPS 467 0.0568
248 STEM CELL TRANSPLANT 141 0.0564
249 WOUND DEHISCENCE 190 0.0562
250 SYSTEMIC CANDIDA 141 0.0561
251 ATELECTASIS 538 0.0556
252 SMALL INTESTINAL OBSTRUCTION 684 0.0555
253 STAPHYLOCOCCUS TEST POSITIVE 117 0.0555
254 VENTRICULAR DYSFUNCTION 143 0.0551
255 RENAL TUBULAR NECROSIS 540 0.0550
256 ALANINE AMINOTRANSFERASE ABNORMAL 116 0.0550
257 CEREBRAL ISCHAEMIA 281 0.0546
258 ESCHERICHIA SEPSIS 158 0.0545
259 SUSPECTED OFF LABEL USE 245 0.0542
260 THROMBOCYTOSIS 197 0.0537
261 LYMPHOPENIA 760 0.0537
262 ACUTE CORONARY SYNDROME 442 0.0533
263 HYPOTHYROIDISM 1704 0.0533
264 BONE MARROW DISORDER 160 0.0529
265 STAPHYLOCOCCAL BACTERAEMIA 229 0.0526
266 PLATELET COUNT DECREASED 5566 0.0522
267 THROMBOTIC THROMBOCYTOPENIC PURPURA 184 0.0522
268 HYPONATRAEMIA 2935 0.0521
269 STOMATITIS 3155 0.0520
270 HEPATOTOXICITY 1157 0.0519
271 HEPATIC FUNCTION ABNORMAL 1933 0.0517
272 ILEUS PARALYTIC 231 0.0517
273 PANCREATIC CARCINOMA METASTATIC 147 0.0516
274 LUNG OPACITY 136 0.0516
275 AGRANULOCYTOSIS 959 0.0515
276 DIVERTICULAR PERFORATION 106 0.0515
277 MYOSITIS 462 0.0514
278 ACUTE RESPIRATORY DISTRESS SYNDROME 905 0.0511
279 IMMUNE-MEDIATED MYOSITIS 141 0.0511
280 OESOPHAGEAL VARICES HAEMORRHAGE 111 0.0511
281 GUILLAIN-BARRE SYNDROME 247 0.0510
282 HYPERTHYROIDISM 739 0.0510
283 SEPSIS 5667 0.0508
284 LARYNGEAL OEDEMA 312 0.0506
285 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 298 0.0503
286 BRONCHOSPASM 716 0.0501
287 HAEMOLYTIC ANAEMIA 449 0.0501
288 PNEUMOTHORAX 792 0.0499
289 HYPERTHERMIA 381 0.0499
290 HEPATITIS B REACTIVATION 158 0.0497
291 HAIR COLOUR CHANGES 618 0.0496
292 MADAROSIS 573 0.0493
293 DERMATOMYOSITIS 125 0.0493
294 ABDOMINAL ABSCESS 216 0.0488
295 CLOSTRIDIAL INFECTION 165 0.0487
296 WHITE BLOOD CELL COUNT DECREASED 5250 0.0484
297 ANAPHYLACTIC SHOCK 1244 0.0482
298 THROMBOPHLEBITIS 169 0.0482
299 CLOSTRIDIUM DIFFICILE COLITIS 509 0.0480
300 PAPILLOEDEMA 215 0.0476
301 RECURRENT CANCER 194 0.0475
302 DRUG RESISTANCE 1220 0.0474
303 ABDOMINAL INFECTION 121 0.0473
304 KLEBSIELLA INFECTION 238 0.0470
305 JAUNDICE CHOLESTATIC 166 0.0469
306 BACTERIAL SEPSIS 153 0.0469
307 PLEURAL EFFUSION 2856 0.0469
308 TUBULOINTERSTITIAL NEPHRITIS 878 0.0468
309 LUNG CANCER METASTATIC 135 0.0468
310 ENCEPHALITIS 324 0.0468
311 MALNUTRITION 523 0.0467
312 TROPONIN INCREASED 354 0.0465
313 DEHYDRATION 6170 0.0462
314 HAIR TEXTURE ABNORMAL 618 0.0462
315 PULMONARY HAEMORRHAGE 360 0.0460
316 LUNG INFILTRATION 406 0.0459
317 DUODENAL ULCER 324 0.0459
318 FIBROSIS 141 0.0458
319 ANAPHYLACTOID REACTION 188 0.0456
320 HAEMOGLOBIN ABNORMAL 293 0.0455
321 OESOPHAGEAL CANDIDIASIS 180 0.0451
322 RASH MACULO-PAPULAR 1004 0.0451
323 VENTRICULAR HYPOKINESIA 144 0.0448
324 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 170 0.0445
325 PULMONARY EMBOLISM 4227 0.0444
326 NECROSIS 247 0.0443
327 IMMUNE THROMBOCYTOPENIC PURPURA 125 0.0442
328 EJECTION FRACTION DECREASED 682 0.0438
329 STAPHYLOCOCCAL SEPSIS 215 0.0435
330 BLOOD MAGNESIUM DECREASED 375 0.0434
331 GRANULOCYTOPENIA 246 0.0431
332 HAEMOPTYSIS 1195 0.0428
333 LYMPHOCYTE COUNT DECREASED 756 0.0427
334 SUDDEN DEATH 442 0.0417
335 APLASTIC ANAEMIA 217 0.0415
336 HYPERURICAEMIA 170 0.0413
337 HYPOXIA 1455 0.0413
338 CARDIAC TAMPONADE 196 0.0412
339 PNEUMOCYSTIS JIROVECII PNEUMONIA 410 0.0408
340 RESPIRATORY FAILURE 2970 0.0407
341 ORAL FUNGAL INFECTION 111 0.0405
342 CHOLESTASIS 777 0.0404
343 ANOREXIA 521 0.0404
344 NECROTISING FASCIITIS 142 0.0402
345 RASH PUSTULAR 292 0.0401
346 DUODENITIS 123 0.0401
347 TYPE 1 DIABETES MELLITUS 241 0.0400
348 UROSEPSIS 369 0.0400
349 BREAST CANCER RECURRENT 126 0.0398
350 COLITIS ISCHAEMIC 269 0.0398
351 MIXED LIVER INJURY 119 0.0395
352 GENERAL PHYSICAL HEALTH DETERIORATION 4566 0.0394
353 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1114 0.0393
354 ENTEROCOCCAL INFECTION 189 0.0391
355 HEPATITIS B 233 0.0386
356 NORMOCHROMIC NORMOCYTIC ANAEMIA 116 0.0386
357 HYPOPHAGIA 987 0.0386
358 PNEUMONIA BACTERIAL 354 0.0385
359 ACUTE LYMPHOCYTIC LEUKAEMIA 109 0.0385
360 SINUS TACHYCARDIA 546 0.0384
361 ENCEPHALOPATHY 944 0.0384
362 ERYTHEMA MULTIFORME 357 0.0382
363 CARDIOMYOPATHY 564 0.0381
364 MULTIPLE-DRUG RESISTANCE 118 0.0380
365 AMYLASE INCREASED 140 0.0379
366 WHITE BLOOD CELL COUNT ABNORMAL 242 0.0379
367 DEEP VEIN THROMBOSIS 2460 0.0378
368 DERMATITIS BULLOUS 273 0.0377
369 ISCHAEMIA 173 0.0376
370 DRUG TOXICITY 510 0.0374
371 TRANSAMINASES INCREASED 831 0.0373
372 NON-CARDIAC CHEST PAIN 118 0.0373
373 SUPRAVENTRICULAR TACHYCARDIA 357 0.0373
374 ACUTE KIDNEY INJURY 5666 0.0370
375 RENAL FAILURE ACUTE 1568 0.0369
376 TOXIC SKIN ERUPTION 372 0.0369
377 TACHYPNOEA 499 0.0367
378 CARDIAC FAILURE ACUTE 244 0.0366
379 PULSE ABSENT 174 0.0365
380 HYPERTRIGLYCERIDAEMIA 213 0.0363
381 HISTIOCYTOSIS HAEMATOPHAGIC 108 0.0363
382 ESCHERICHIA INFECTION 299 0.0363
383 TONGUE OEDEMA 137 0.0359
384 NEPHROTIC SYNDROME 246 0.0358
385 CARBOHYDRATE ANTIGEN 125 INCREASED 122 0.0357
386 TOXIC EPIDERMAL NECROLYSIS 543 0.0357
387 CARDIAC DYSFUNCTION 133 0.0357
388 CATHETER SITE INFECTION 135 0.0357
389 ORAL CANDIDIASIS 468 0.0355
390 SPLENOMEGALY 414 0.0353
391 DIASTOLIC DYSFUNCTION 109 0.0353
392 INFUSION RELATED REACTION 2328 0.0351
393 PLATELET COUNT ABNORMAL 212 0.0350
394 PULMONARY FIBROSIS 671 0.0349
395 FLUID INTAKE REDUCED 175 0.0349
396 BLOOD BILIRUBIN INCREASED 944 0.0349
397 HEPATITIS 893 0.0349
398 RESPIRATORY DISTRESS 961 0.0348
399 OVARIAN CANCER 321 0.0348
400 SKIN REACTION 490 0.0347
401 HEPATIC FAILURE 1048 0.0347
402 DEVICE RELATED INFECTION 535 0.0347
403 ACUTE RESPIRATORY FAILURE 667 0.0346
404 TUMOUR MARKER INCREASED 166 0.0346
405 BRONCHOPULMONARY ASPERGILLOSIS 268 0.0345
406 PERICARDIAL EFFUSION 797 0.0344
407 HEPATIC CYST 117 0.0344
408 TOXIC ENCEPHALOPATHY 174 0.0343
409 DERMATITIS EXFOLIATIVE GENERALISED 119 0.0342
410 BLOOD CREATININE INCREASED 2234 0.0342
411 BREAST CANCER METASTATIC 367 0.0341
412 HYPERCALCAEMIA 420 0.0340
413 LEUKOCYTOSIS 615 0.0339
414 CANDIDIASIS 136 0.0339
415 ASPARTATE AMINOTRANSFERASE INCREASED 1800 0.0339
416 ATRIAL FLUTTER 270 0.0338
417 HYPERTENSIVE CRISIS 376 0.0338
418 PROTEIN TOTAL DECREASED 127 0.0337
419 HAEMATOCRIT DECREASED 668 0.0337
420 RENAL IMPAIRMENT 2822 0.0336
421 DISEASE RECURRENCE 1592 0.0334
422 FIBRIN D DIMER INCREASED 118 0.0332
423 PNEUMONIA FUNGAL 130 0.0329
424 PROCTALGIA 210 0.0326
425 HYPERNATRAEMIA 162 0.0325
426 ALANINE AMINOTRANSFERASE INCREASED 1992 0.0324
427 BLOOD ALKALINE PHOSPHATASE INCREASED 804 0.0323
428 LEFT VENTRICULAR FAILURE 111 0.0322
429 OLIGURIA 200 0.0322
430 BONE LESION 116 0.0321
431 SHOCK HAEMORRHAGIC 260 0.0319
432 DRUG-INDUCED LIVER INJURY 1002 0.0319
433 BLOOD SODIUM DECREASED 601 0.0319
434 PYREXIA 10992 0.0317
435 ESCHERICHIA URINARY TRACT INFECTION 135 0.0317
436 CEREBRAL INFARCTION 773 0.0316
437 PERITONITIS 652 0.0314
438 PHLEBITIS 160 0.0312
439 HYPOGAMMAGLOBULINAEMIA 205 0.0312
440 HAEMOGLOBIN DECREASED 3202 0.0312
441 ACUTE PULMONARY OEDEMA 175 0.0311
442 PYELONEPHRITIS 270 0.0311
443 C-REACTIVE PROTEIN INCREASED 1133 0.0311
444 BLOOD UREA INCREASED 521 0.0311
445 OXYGEN SATURATION DECREASED 1747 0.0311
446 PULMONARY ALVEOLAR HAEMORRHAGE 174 0.0310
447 CYTOMEGALOVIRUS INFECTION REACTIVATION 137 0.0310
448 TRISMUS 160 0.0310
449 MULTI-ORGAN FAILURE 535 0.0309
450 CONGESTIVE CARDIOMYOPATHY 128 0.0307
451 CIRCULATORY COLLAPSE 523 0.0307
452 DERMATITIS 642 0.0306
453 GAMMA-GLUTAMYLTRANSFERASE INCREASED 675 0.0304
454 ABDOMINAL TENDERNESS 151 0.0304
455 HEPATOCELLULAR INJURY 431 0.0304
456 AUTOIMMUNE HEPATITIS 210 0.0302
457 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 249 0.0302
458 MYOCARDIAL ISCHAEMIA 343 0.0301
459 PNEUMONIA ASPIRATION 751 0.0300
460 DYSPHAGIA 2840 0.0299
461 OESOPHAGEAL ULCER 115 0.0299
462 LUNG NEOPLASM 127 0.0297
463 SHOCK 683 0.0297
464 SARCOIDOSIS 141 0.0297
465 VOMITING 13896 0.0295
466 DECREASED APPETITE 6854 0.0295
467 ENDOCARDITIS 151 0.0294
468 CARDIOPULMONARY FAILURE 114 0.0292
469 BLOOD CREATINE INCREASED 129 0.0291
470 LYMPHOMA 447 0.0289
471 PSEUDOMONAS INFECTION 248 0.0289
472 ACUTE MYOCARDIAL INFARCTION 851 0.0288
473 ANAPHYLACTIC REACTION 1589 0.0287
474 CYANOSIS 450 0.0286
475 DRUG ERUPTION 507 0.0286
476 VENTRICULAR FIBRILLATION 316 0.0284
477 NEUTROPHIL COUNT INCREASED 291 0.0284
478 PURPURA 251 0.0283
479 HEPATIC ENCEPHALOPATHY 264 0.0283
480 VASCULAR DEVICE INFECTION 128 0.0282
481 TACHYCARDIA 2501 0.0281
482 FAECALOMA 154 0.0281
483 CHOLECYSTITIS 334 0.0280
484 INTESTINAL OBSTRUCTION 1039 0.0275
485 LIVER INJURY 676 0.0275
486 CREATININE RENAL CLEARANCE DECREASED 110 0.0275
487 LYMPHADENOPATHY 970 0.0274
488 METABOLIC DISORDER 159 0.0274
489 CARDIOGENIC SHOCK 391 0.0272
490 ISCHAEMIC STROKE 484 0.0271
491 FISTULA 304 0.0270
492 RED CELL DISTRIBUTION WIDTH INCREASED 112 0.0269
493 HEPATITIS ACUTE 175 0.0269
494 INFLAMMATORY MARKER INCREASED 133 0.0268
495 BODY TEMPERATURE INCREASED 544 0.0266
496 DEAFNESS 688 0.0263
497 PATHOLOGICAL FRACTURE 133 0.0262
498 CHOLECYSTITIS ACUTE 147 0.0259
499 DIARRHOEA 16722 0.0259
500 HAEMOLYSIS 200 0.0259
501 ASPIRATION 282 0.0257
502 PULMONARY MASS 383 0.0257
503 NEUTROPHILIA 146 0.0256
504 HYPERGLYCAEMIA 935 0.0256
505 HEPATITIS CHOLESTATIC 154 0.0255
506 FLANK PAIN 239 0.0255
507 CANDIDA INFECTION 430 0.0254
508 BLOOD LACTIC ACID INCREASED 134 0.0254
509 HAEMATEMESIS 644 0.0254
510 HYPERKALAEMIA 890 0.0254
511 LIP OEDEMA 107 0.0252
512 BLOOD CALCIUM DECREASED 284 0.0252
513 LIPASE INCREASED 193 0.0252
514 HAEMATURIA 861 0.0251
515 NEOPLASM 288 0.0250
516 LUNG INFECTION 389 0.0250
517 HYPOTENSION 5000 0.0249
518 MOUTH ULCERATION 522 0.0247
519 ANURIA 213 0.0247
520 NAIL DISORDER 216 0.0247
521 SKIN NECROSIS 128 0.0246
522 COVID-19 PNEUMONIA 290 0.0245
523 ATAXIA 291 0.0245
524 POLYARTHRITIS 128 0.0243
525 PROTEIN URINE PRESENT 121 0.0242
526 EPISTAXIS 1813 0.0242
527 HYDROCEPHALUS 131 0.0240
528 ABDOMINAL PAIN 5590 0.0240
529 ATRIAL FIBRILLATION 2334 0.0239
530 THROAT TIGHTNESS 647 0.0239
531 MENTAL STATUS CHANGES 654 0.0235
532 RENAL FAILURE 3111 0.0234
533 WOUND INFECTION 256 0.0234
534 HAEMODYNAMIC INSTABILITY 178 0.0233
535 FOETAL GROWTH RESTRICTION 142 0.0233
536 CHILLS 2706 0.0231
537 ACIDOSIS 176 0.0230
538 MENINGITIS 153 0.0229
539 ALTERED STATE OF CONSCIOUSNESS 494 0.0228
540 CYTOMEGALOVIRUS INFECTION 376 0.0226
541 THERAPY NON-RESPONDER 1016 0.0226
542 CARDIO-RESPIRATORY ARREST 945 0.0226
543 NAUSEA 17732 0.0224
544 HEMIPARESIS 379 0.0224
545 INFECTION 3225 0.0223
546 DIARRHOEA HAEMORRHAGIC 208 0.0222
547 GRAFT VERSUS HOST DISEASE 160 0.0222
548 BRAIN OEDEMA 281 0.0222
549 PROTHROMBIN TIME PROLONGED 133 0.0222
550 PANCREATITIS ACUTE 498 0.0221
551 LYMPHOEDEMA 153 0.0221
552 DYSARTHRIA 832 0.0221
553 URINE OUTPUT DECREASED 192 0.0219
554 ASTHENIA 8241 0.0219
555 BREATH SOUNDS ABNORMAL 108 0.0219
556 HERPES SIMPLEX 142 0.0218
557 GENERALISED OEDEMA 269 0.0217
558 VASCULITIS 253 0.0217
559 GASTROINTESTINAL INFLAMMATION 170 0.0217
560 REFUSAL OF TREATMENT BY PATIENT 141 0.0216
561 GASTROENTERITIS 315 0.0216
562 PHARYNGOLARYNGEAL PAIN 113 0.0212
563 FLUSHING 2159 0.0212
564 UPPER GASTROINTESTINAL HAEMORRHAGE 357 0.0212
565 NEUROLOGICAL SYMPTOM 121 0.0211
566 MELAENA 464 0.0211
567 STAPHYLOCOCCAL INFECTION 693 0.0210
568 BLOOD DISORDER 168 0.0209
569 BLOOD POTASSIUM DECREASED 630 0.0209
570 BACTERIAL INFECTION 390 0.0209
571 OFF LABEL USE 18205 0.0208
572 ANGIOPATHY 116 0.0207
573 PNEUMONIA 6691 0.0206
574 PETECHIAE 215 0.0206
575 JAUNDICE 551 0.0205
576 PIGMENTATION DISORDER 126 0.0204
577 PRODUCT USE IN UNAPPROVED INDICATION 5051 0.0204
578 ATRIOVENTRICULAR BLOCK COMPLETE 136 0.0203
579 TEMPERATURE INTOLERANCE 209 0.0202
580 MYASTHENIA GRAVIS 163 0.0202
581 FACE OEDEMA 338 0.0200
582 EMPHYSEMA 202 0.0200
583 ERYTHEMA 4116 0.0200
584 APHTHOUS ULCER 155 0.0200
585 HEPATOMEGALY 196 0.0199
586 SKIN HYPERPIGMENTATION 171 0.0199
587 RENAL FAILURE CHRONIC 153 0.0199
588 GENERAL PHYSICAL CONDITION ABNORMAL 133 0.0196
589 PARAESTHESIA ORAL 282 0.0195
590 ORTHOSTATIC HYPOTENSION 340 0.0195
591 UNRESPONSIVE TO STIMULI 503 0.0195
592 CARDIAC FAILURE 1562 0.0194
593 DYSPNOEA EXERTIONAL 726 0.0193
594 GASTRIC ULCER 366 0.0192
595 STREPTOCOCCAL INFECTION 107 0.0192
596 PLEURISY 114 0.0192
597 LIVER DISORDER 851 0.0192
598 RALES 111 0.0191
599 SUBARACHNOID HAEMORRHAGE 194 0.0190
600 OROPHARYNGEAL DISCOMFORT 172 0.0190
601 STEVENS-JOHNSON SYNDROME 423 0.0190
602 SKIN DISORDER 634 0.0190
603 EYELID PTOSIS 193 0.0190
604 CONSTIPATION 4113 0.0188
605 HAEMODIALYSIS 157 0.0187
606 TONGUE DISORDER 135 0.0186
607 GASTRITIS 489 0.0186
608 ORAL PAIN 416 0.0186
609 LOWER GASTROINTESTINAL HAEMORRHAGE 137 0.0185
610 RESPIRATORY TRACT INFECTION 482 0.0185
611 PARAESTHESIA 2904 0.0184
612 DYSPNOEA 10438 0.0184
613 CARDIAC ARREST 1522 0.0184
614 RED BLOOD CELL COUNT DECREASED 526 0.0184
615 ASPHYXIA 150 0.0184
616 SYNCOPE 1836 0.0183
617 COAGULOPATHY 305 0.0183
618 IMPAIRED QUALITY OF LIFE 262 0.0182
619 ACUTE HEPATIC FAILURE 248 0.0181
620 ABSCESS 288 0.0180
621 VENTRICULAR TACHYCARDIA 298 0.0180
622 IMMUNOSUPPRESSION 158 0.0179
623 ARTERIOSCLEROSIS CORONARY ARTERY 118 0.0178
624 ALOPECIA 3473 0.0177
625 PRESYNCOPE 429 0.0176
626 HYPERTENSION 3735 0.0176
627 LUNG DISORDER 864 0.0176
628 MITRAL VALVE INCOMPETENCE 199 0.0176
629 METABOLIC ACIDOSIS 562 0.0176
630 STATUS EPILEPTICUS 197 0.0174
631 HEMIPLEGIA 145 0.0174
632 DELIRIUM 604 0.0174
633 WHITE BLOOD CELL COUNT INCREASED 666 0.0173
634 COLON CANCER 257 0.0172
635 POST PROCEDURAL COMPLICATION 331 0.0172
636 NO THERAPEUTIC RESPONSE 210 0.0172
637 SINUS BRADYCARDIA 165 0.0171
638 RENAL CYST 135 0.0170
639 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 132 0.0170
640 TOXICITY TO VARIOUS AGENTS 2863 0.0170
641 PALLOR 461 0.0169
642 APHASIA 509 0.0168
643 CHEST DISCOMFORT 1726 0.0168
644 COLD SWEAT 296 0.0168
645 OEDEMA 896 0.0165
646 PLATELET COUNT INCREASED 214 0.0164
647 FOLLICULITIS 171 0.0163
648 BLOOD THYROID STIMULATING HORMONE INCREASED 150 0.0163
649 OSTEONECROSIS OF JAW 402 0.0162
650 PEMPHIGOID 122 0.0162
651 FEELING HOT 991 0.0161
652 FACIAL PARALYSIS 137 0.0161
653 BRONCHIECTASIS 108 0.0160
654 RECTAL HAEMORRHAGE 687 0.0160
655 MOUTH HAEMORRHAGE 117 0.0159
656 TRICUSPID VALVE INCOMPETENCE 126 0.0158
657 ANGINA PECTORIS 452 0.0158
658 PERICARDITIS 265 0.0158
659 HYPERSENSITIVITY 2920 0.0157
660 OEDEMA PERIPHERAL 1909 0.0156
661 ORAL DISORDER 114 0.0155
662 RESPIRATORY RATE INCREASED 138 0.0155
663 VENTRICULAR EXTRASYSTOLES 161 0.0155
664 BLOOD PRESSURE DECREASED 1023 0.0154
665 DYSURIA 566 0.0154
666 GENERALISED TONIC-CLONIC SEIZURE 253 0.0153
667 CLOSTRIDIUM DIFFICILE INFECTION 333 0.0152
668 DEPRESSED LEVEL OF CONSCIOUSNESS 603 0.0152
669 EYELID OEDEMA 177 0.0152
670 GASTROINTESTINAL DISORDER 1362 0.0152
671 HEPATIC STEATOSIS 281 0.0151
672 GASTRIC HAEMORRHAGE 173 0.0150
673 RETINAL HAEMORRHAGE 107 0.0150
674 CHEST PAIN 2766 0.0149
675 GASTROINTESTINAL HAEMORRHAGE 1232 0.0147
676 RETINAL DETACHMENT 135 0.0147
677 TASTE DISORDER 297 0.0146
678 BONE PAIN 853 0.0145
679 NERVOUS SYSTEM DISORDER 452 0.0145
680 SENSATION OF FOREIGN BODY 122 0.0145
681 URINARY RETENTION 483 0.0145
682 GRAND MAL CONVULSION 133 0.0144
683 MUSCULOSKELETAL CHEST PAIN 222 0.0143
684 CONJUNCTIVITIS 265 0.0143
685 PULMONARY OEDEMA 639 0.0143
686 DIABETIC KETOACIDOSIS 341 0.0142
687 NEPHROPATHY 132 0.0141
688 SPINAL OSTEOARTHRITIS 124 0.0141
689 ANAL INCONTINENCE 126 0.0140
690 HYPOAESTHESIA ORAL 210 0.0139
691 PRODUCTIVE COUGH 665 0.0139
692 MYOPATHY 120 0.0139
693 GINGIVAL BLEEDING 189 0.0138
694 FEEDING DISORDER 280 0.0138
695 HYPERHIDROSIS 1763 0.0137
696 CELLULITIS 689 0.0137
697 TRANSFUSION 143 0.0136
698 NEURALGIA 331 0.0136
699 RASH 5890 0.0135
700 EPILEPSY 413 0.0135
701 DERMATITIS ALLERGIC 169 0.0134
702 PLASMA CELL MYELOMA 524 0.0134
703 HYPOTONIA 134 0.0134
704 SQUAMOUS CELL CARCINOMA 125 0.0133
705 THROMBOSIS 1065 0.0132
706 HYPOTHERMIA 134 0.0132
707 DYSPHONIA 771 0.0132
708 TREATMENT FAILURE 1089 0.0131
709 LEUKAEMIA 124 0.0131
710 DECUBITUS ULCER 107 0.0131
711 HAEMORRHAGE 1370 0.0131
712 DYSGEUSIA 971 0.0131
713 SPINAL COMPRESSION FRACTURE 108 0.0130
714 APPENDICITIS 122 0.0130
715 SKIN LESION 355 0.0129
716 ABDOMINAL PAIN LOWER 326 0.0129
717 PERIPHERAL COLDNESS 177 0.0129
718 DRUG INTOLERANCE 1241 0.0128
719 URINARY TRACT INFECTION 2176 0.0127
720 SKIN INFECTION 143 0.0127
721 FATIGUE 9895 0.0127
722 ARTERIOSCLEROSIS 119 0.0126
723 LOSS OF CONSCIOUSNESS 1619 0.0126
724 GROIN PAIN 110 0.0125
725 MASS 174 0.0124
726 INCONTINENCE 131 0.0124
727 DIVERTICULITIS 341 0.0123
728 TINNITUS 562 0.0122
729 WEIGHT DECREASED 3412 0.0122
730 DIPLOPIA 317 0.0122
731 HAEMORRHAGE INTRACRANIAL 182 0.0122
732 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 864 0.0121
733 ULCER 192 0.0121
734 MOTOR DYSFUNCTION 122 0.0120
735 GLOMERULAR FILTRATION RATE DECREASED 147 0.0120
736 RETCHING 254 0.0119
737 CEREBRAL HAEMORRHAGE 424 0.0118
738 ARRHYTHMIA 558 0.0118
739 CONFUSIONAL STATE 1881 0.0116
740 LACRIMATION INCREASED 350 0.0116
741 RESPIRATORY DISORDER 346 0.0116
742 DISORIENTATION 456 0.0115
743 HYPOAESTHESIA 1705 0.0114
744 BODY TEMPERATURE DECREASED 112 0.0114
745 THYROID DISORDER 175 0.0113
746 SENSORY DISTURBANCE 182 0.0113
747 CARDIOMEGALY 139 0.0113
748 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 620 0.0113
749 SKIN ULCER 290 0.0112
750 BRADYCARDIA 594 0.0112
751 SALIVARY HYPERSECRETION 112 0.0112
752 INTERNATIONAL NORMALISED RATIO INCREASED 317 0.0111
753 PARALYSIS 159 0.0111
754 COUGH 3090 0.0110
755 URINARY INCONTINENCE 325 0.0110
756 SKIN FISSURES 214 0.0109
757 TENDERNESS 114 0.0109
758 SPEECH DISORDER 573 0.0109
759 LIVER FUNCTION TEST ABNORMAL 318 0.0109
760 THERAPEUTIC RESPONSE DECREASED 655 0.0108
761 INTENTIONAL PRODUCT USE ISSUE 942 0.0107
762 LETHARGY 618 0.0107
763 INFLAMMATION 550 0.0106
764 PHARYNGITIS 131 0.0106
765 IMMUNE SYSTEM DISORDER 139 0.0105
766 RASH ERYTHEMATOUS 504 0.0105
767 PULMONARY HYPERTENSION 219 0.0105
768 MUSCULAR WEAKNESS 1193 0.0105
769 LIVER FUNCTION TEST INCREASED 225 0.0105
770 DRUG INTERACTION 1662 0.0105
771 COMA 496 0.0104
772 OSTEONECROSIS 342 0.0104
773 COGNITIVE DISORDER 484 0.0104
774 SPINAL PAIN 120 0.0102
775 DEATH 8806 0.0102
776 OBSTRUCTIVE AIRWAYS DISORDER 112 0.0101
777 FEELING COLD 280 0.0100
778 IMPAIRED HEALING 329 0.0100
779 HAEMORRHOIDS 195 0.0100
780 TRANSIENT ISCHAEMIC ATTACK 335 0.0099
781 CENTRAL NERVOUS SYSTEM LESION 136 0.0099
782 BACK PAIN 2282 0.0098
783 PELVIC PAIN 178 0.0098
784 POST PROCEDURAL HAEMORRHAGE 114 0.0098
785 NODULE 127 0.0097
786 HEPATIC ENZYME INCREASED 662 0.0097
787 BLOOD CREATINE PHOSPHOKINASE INCREASED 274 0.0095
788 RESPIRATORY ARREST 261 0.0095
789 ABDOMINAL DISTENSION 987 0.0094
790 HEPATIC CIRRHOSIS 177 0.0094
791 CYSTITIS 299 0.0094
792 HAEMATOCHEZIA 513 0.0093
793 CONVULSION 530 0.0093
794 HERPES ZOSTER 532 0.0092
795 BLOOD POTASSIUM INCREASED 150 0.0092
796 LUNG NEOPLASM MALIGNANT 379 0.0092
797 PRURITUS 3532 0.0092
798 PULMONARY CONGESTION 121 0.0092
799 MALAISE 4017 0.0092
800 ELECTROCARDIOGRAM QT PROLONGED 329 0.0091
801 PANCREATITIS 480 0.0091
802 HAEMATOMA 234 0.0090
803 FUNGAL INFECTION 301 0.0090
804 EATING DISORDER 192 0.0090
805 LACTIC ACIDOSIS 291 0.0090
806 PULMONARY ARTERIAL HYPERTENSION 130 0.0090
807 DEVICE OCCLUSION 126 0.0089
808 MUSCULOSKELETAL PAIN 467 0.0089
809 ILL-DEFINED DISORDER 534 0.0088
810 IMMUNODEFICIENCY 131 0.0088
811 DIALYSIS 124 0.0087
812 SUBDURAL HAEMATOMA 125 0.0087
813 CONDITION AGGRAVATED 2644 0.0087
814 HIATUS HERNIA 112 0.0086
815 RENAL DISORDER 399 0.0086
816 PREMATURE BABY 257 0.0085
817 FULL BLOOD COUNT DECREASED 172 0.0085
818 PRODUCT PRESCRIBING ISSUE 185 0.0085
819 SWOLLEN TONGUE 265 0.0085
820 OSTEOMYELITIS 153 0.0084
821 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 439 0.0084
822 RASH PRURITIC 451 0.0083
823 BLINDNESS 338 0.0083
824 DRUG EFFECT INCOMPLETE 299 0.0082
825 PREMATURE DELIVERY 131 0.0082
826 BLOOD PRESSURE SYSTOLIC INCREASED 159 0.0081
827 HEART RATE INCREASED 807 0.0081
828 CARDIOVASCULAR DISORDER 206 0.0081
829 SEIZURE 937 0.0081
830 COVID-19 1416 0.0081
831 NEOPLASM MALIGNANT 536 0.0080
832 ABDOMINAL PAIN UPPER 1648 0.0080
833 DYSPEPSIA 786 0.0080
834 BONE DISORDER 143 0.0078
835 OROPHARYNGEAL PAIN 718 0.0077
836 ORAL HERPES 151 0.0077
837 LOWER RESPIRATORY TRACT INFECTION 350 0.0077
838 HYPOACUSIS 331 0.0077
839 HOT FLUSH 573 0.0076
840 CORONARY ARTERY DISEASE 230 0.0076
841 VERTIGO 462 0.0076
842 NIGHT SWEATS 244 0.0076
843 LIP SWELLING 252 0.0076
844 PRODUCT USE ISSUE 1419 0.0075
845 RESTLESSNESS 275 0.0075
846 FLUID OVERLOAD 109 0.0075
847 CHOLELITHIASIS 244 0.0074
848 WHEEZING 436 0.0073
849 EOSINOPHILIA 128 0.0073
850 THROAT IRRITATION 327 0.0073
851 RASH PAPULAR 162 0.0072
852 ANGIOEDEMA 318 0.0072
853 UPPER RESPIRATORY TRACT INFECTION 332 0.0072
854 DRY MOUTH 576 0.0071
855 HYPOGLYCAEMIA 344 0.0071
856 BLOOD PRESSURE ABNORMAL 140 0.0070
857 MYALGIA 1190 0.0070
858 PAIN IN JAW 198 0.0070
859 FAECES DISCOLOURED 151 0.0070
860 PALPITATIONS 811 0.0069
861 DIZZINESS 3451 0.0069
862 CEREBROVASCULAR ACCIDENT 1165 0.0069
863 DRUG INEFFECTIVE 8978 0.0068
864 BLOOD PRESSURE INCREASED 1028 0.0067
865 RASH GENERALISED 174 0.0067
866 LOCAL SWELLING 117 0.0067
867 SKIN EXFOLIATION 558 0.0066
868 RHABDOMYOLYSIS 275 0.0066
869 NECK PAIN 367 0.0066
870 CHROMATURIA 144 0.0064
871 GASTRIC CANCER 161 0.0063
872 TREMOR 1048 0.0063
873 MYOCARDIAL INFARCTION 1094 0.0063
874 RASH MACULAR 215 0.0061
875 MUSCLE TWITCHING 140 0.0061
876 VISUAL ACUITY REDUCED 199 0.0060
877 TOOTHACHE 107 0.0059
878 EAR PAIN 114 0.0059
879 URTICARIA 969 0.0058
880 LABORATORY TEST ABNORMAL 170 0.0058
881 PAIN 3521 0.0057
882 POLLAKIURIA 237 0.0057
883 AGITATION 415 0.0056
884 BLOOD URINE PRESENT 107 0.0056
885 CARDIAC FAILURE CONGESTIVE 450 0.0056
886 PRURITUS GENERALISED 121 0.0056
887 RENAL INJURY 165 0.0055
888 ADVERSE EVENT 511 0.0055
889 DRY SKIN 740 0.0055
890 CHRONIC KIDNEY DISEASE 419 0.0055
891 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 161 0.0055
892 DIABETES MELLITUS 410 0.0054
893 PAIN IN EXTREMITY 1557 0.0053
894 VAGINAL HAEMORRHAGE 228 0.0052
895 GASTROOESOPHAGEAL REFLUX DISEASE 422 0.0052
896 BLISTER 289 0.0051
897 SWELLING FACE 330 0.0051
898 BALANCE DISORDER 437 0.0051
899 LIMB DISCOMFORT 156 0.0050
900 MUSCLE SPASMS 922 0.0050
901 BRONCHITIS 367 0.0050
902 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 127 0.0049
903 DISCOMFORT 299 0.0049
904 FLATULENCE 276 0.0049
905 WOUND 136 0.0049
906 HEART RATE IRREGULAR 108 0.0048
907 RHINORRHOEA 308 0.0048
908 SKIN DISCOLOURATION 215 0.0047
909 GAIT DISTURBANCE 895 0.0047
910 VIRAL INFECTION 155 0.0047
911 SOMNOLENCE 934 0.0046
912 FOETAL EXPOSURE DURING PREGNANCY 373 0.0046
913 ARTHRALGIA 1846 0.0044
914 ANXIETY 1263 0.0044
915 VISION BLURRED 609 0.0044
916 FALL 1456 0.0044
917 DRY EYE 218 0.0044
918 AGEUSIA 108 0.0043
919 TYPE 2 DIABETES MELLITUS 145 0.0043
920 ECZEMA 224 0.0043
921 VISUAL IMPAIRMENT 530 0.0043
922 MOVEMENT DISORDER 136 0.0042
923 DISTURBANCE IN ATTENTION 225 0.0042
924 ABDOMINAL DISCOMFORT 696 0.0041
925 HEART RATE DECREASED 145 0.0041
926 HEADACHE 2555 0.0041
927 DEPRESSED MOOD 204 0.0039
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 689 0.0038
929 BURNING SENSATION 266 0.0038
930 MATERNAL EXPOSURE DURING PREGNANCY 327 0.0037
931 PSYCHOTIC DISORDER 107 0.0036
932 GAIT INABILITY 121 0.0036
933 FEMUR FRACTURE 111 0.0036
934 COLITIS ULCERATIVE 160 0.0036
935 ADVERSE DRUG REACTION 319 0.0035
936 TREATMENT NONCOMPLIANCE 193 0.0035
937 SWELLING 329 0.0035
938 FLUID RETENTION 173 0.0034
939 OCULAR HYPERAEMIA 161 0.0034
940 SLEEP DISORDER 238 0.0034
941 INSOMNIA 878 0.0033
942 CARDIAC DISORDER 307 0.0033
943 CATARACT 195 0.0033
944 EXPOSURE DURING PREGNANCY 202 0.0032
945 BLOOD GLUCOSE INCREASED 610 0.0032
946 DEPRESSION 732 0.0032
947 CONTUSION 309 0.0032
948 NEPHROLITHIASIS 147 0.0032
949 PERIPHERAL SWELLING 490 0.0032
950 DYSKINESIA 126 0.0031
951 COLORECTAL CANCER 143 0.0030
952 MOBILITY DECREASED 213 0.0030
953 OSTEOPOROSIS 121 0.0029
954 EMOTIONAL DISTRESS 352 0.0029
955 MEDICATION ERROR 161 0.0029
956 NASAL CONGESTION 167 0.0028
957 SINUSITIS 289 0.0028
958 AMNESIA 182 0.0028
959 ARTHRITIS 220 0.0028
960 INFLUENZA 299 0.0027
961 OSTEOARTHRITIS 113 0.0027
962 INFLUENZA LIKE ILLNESS 218 0.0026
963 SURGERY 153 0.0026
964 HALLUCINATION 194 0.0026
965 MENTAL DISORDER 111 0.0025
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 121 0.0025
967 THERAPY CESSATION 129 0.0025
968 ACNE 188 0.0025
969 AGGRESSION 123 0.0025
970 UNEVALUABLE EVENT 184 0.0024
971 WEIGHT INCREASED 541 0.0024
972 MUSCULOSKELETAL STIFFNESS 209 0.0024
973 MEMORY IMPAIRMENT 318 0.0023
974 FEELING ABNORMAL 547 0.0023
975 UNDERDOSE 165 0.0023
976 NO ADVERSE EVENT 402 0.0022
977 BREAST CANCER 197 0.0021
978 ARTHROPATHY 116 0.0021
979 EYE PAIN 117 0.0021
980 NASOPHARYNGITIS 362 0.0020
981 PROSTATE CANCER 146 0.0018
982 INJURY 119 0.0017
983 THERAPY INTERRUPTED 117 0.0016
984 ASTHMA 180 0.0016
985 JOINT SWELLING 190 0.0016
986 OVERDOSE 330 0.0015
987 SKIN BURNING SENSATION 108 0.0015
988 RHEUMATOID ARTHRITIS 164 0.0014
989 MIGRAINE 119 0.0012
990 HOSPITALISATION 187 0.0012
991 ILLNESS 121 0.0012
992 PSORIASIS 146 0.0011
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 176 0.0009
994 INCORRECT DOSE ADMINISTERED 179 0.0008
995 PRODUCT DOSE OMISSION ISSUE 118 0.0004
996 INJECTION SITE PAIN 115 0.0004